Zevra Net Interest Income from 2010 to 2026
| ZVRA Stock | 8.50 0.10 1.19% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter -6 M | Current Value -5.7 M | Quarterly Volatility 3 M |
Check Zevra Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zevra Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.7 M, Selling General Administrative of 66.3 M or Other Operating Expenses of 133.6 M, as well as many indicators such as Price To Sales Ratio of 15.44, Dividend Yield of 0.0 or PTB Ratio of 9.19. Zevra financial statements analysis is a perfect complement when working with Zevra Therapeutics Valuation or Volatility modules.
Zevra | Net Interest Income | Build AI portfolio with Zevra Stock |
Analyzing Zevra Therapeutics's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Zevra Therapeutics's current valuation and future prospects.
Latest Zevra Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Zevra Therapeutics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Zevra Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zevra Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Zevra Net Interest Income Regression Statistics
| Arithmetic Mean | (4,814,305) | |
| Coefficient Of Variation | (63.19) | |
| Mean Deviation | 2,168,696 | |
| Median | (6,205,000) | |
| Standard Deviation | 3,041,972 | |
| Sample Variance | 9.3T | |
| Range | 10.7M | |
| R-Value | 0.43 | |
| Mean Square Error | 8.1T | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 257,348 | |
| Total Sum of Squares | 148.1T |
Zevra Net Interest Income History
About Zevra Therapeutics Financial Statements
Zevra Therapeutics stakeholders use historical fundamental indicators, such as Zevra Therapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Zevra Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zevra Therapeutics' assets and liabilities are reflected in the revenues and expenses on Zevra Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zevra Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -6 M | -5.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zevra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zevra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zevra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zevra Therapeutics Stock:Check out the analysis of Zevra Therapeutics Correlation against competitors. For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zevra Therapeutics. Anticipated expansion of Zevra directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zevra Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth 6.054 | Return On Assets | Return On Equity |
Understanding Zevra Therapeutics requires distinguishing between market price and book value, where the latter reflects Zevra's accounting equity. The concept of intrinsic value - what Zevra Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zevra Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Zevra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zevra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zevra Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.